Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Evercore ISI Group Reinstates In-Line on Quest Diagnostics, Announces $165 Price Target

Author: Benzinga Newsdesk | August 28, 2024 08:37am

Evercore ISI Group analyst Elizabeth Anderson reinstates Quest Diagnostics (NYSE:DGX) with a In-Line and announces $165 price target.

Posted In: DGX